Breaking News Instant updates and real-time market news.

CVS

CVS Health

$79.12

1.15 (1.47%)

08:39
08/08/17
08/08
08:39
08/08/17
08:39

CVS Health sees Q3 net revenue growth of 2.75%-4.25%, consensus $46.37B

  • 08

    Aug

  • 21

    Sep

  • 22

    Sep

CVS CVS Health
$79.12

1.15 (1.47%)

06/27/17
LEER
06/27/17
NO CHANGE
Target $90
LEER
Outperform
CVS gained largest PBM share in 2017 selling season, says Leerink
Leerink analyst David Larsen says his firm's recently published Pharmacy Benefit Manager survey shows that CVS Health is the largest share gainer in the 2017 selling season. The company is poised to win incremental PBM and Specialty Pharmacy share, while the Optum and Cigna deals will start to benefit retail volumes in the near-term, Larsen tells investors in a research note. He keeps an Outperform rating on CVS shares with a $90 price target.
06/27/17
NEED
06/27/17
INITIATION
NEED
Hold
CVS Health initiated with a Hold at Needham
Needham analyst Kevin Caliendo initiated CVS Health with a Hold.
06/28/17
06/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altaba (AABA) initiated with an Overweight at JPMorgan. 2. Aetna (AET) and Humana (HUM) were initiated with a Buy at Citi. The firm also added Aetna to its Focus List. 3. CVS Health (CVS) and Walgreens Boots Alliance (WBA) were initiated with a Hold at Needham. 4. Oaktree Capital (OAK) initiated with a Hold at Jefferies. 5. General Motors (GM) resumed with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.

TODAY'S FREE FLY STORIES

DY

Dycom

$84.52

1.04 (1.25%)

10:26
09/19/18
09/19
10:26
09/19/18
10:26
Conference/Events
Dycom management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CSL

Carlisle

$127.72

0.13 (0.10%)

10:25
09/19/18
09/19
10:25
09/19/18
10:25
Conference/Events
Carlisle management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CBB

Cincinnati Bell

$14.85

-0.2 (-1.33%)

10:24
09/19/18
09/19
10:24
09/19/18
10:24
Conference/Events
Cincinnati Bell management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

XYF

X Financial

$0.00

(0.00%)

10:23
09/19/18
09/19
10:23
09/19/18
10:23
Syndicate
Breaking Syndicate news story on X Financial »

X Financial indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

BRKR

Bruker

$34.93

0.05 (0.14%)

10:23
09/19/18
09/19
10:23
09/19/18
10:23
Conference/Events
Bruker management to meet with Leerink »

Meeting to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

BPI

Bridgepoint Education

$10.45

0.02 (0.19%)

10:22
09/19/18
09/19
10:22
09/19/18
10:22
Conference/Events
Bridgepoint Education management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 27

    Sep

ARPO

Aerpio Pharmaceuticals

$3.71

-0.055 (-1.46%)

, VCRA

Vocera

$34.50

0.99 (2.95%)

10:22
09/19/18
09/19
10:22
09/19/18
10:22
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

ARPO

Aerpio Pharmaceuticals

$3.71

-0.055 (-1.46%)

VCRA

Vocera

$34.50

0.99 (2.95%)

VNE

Veoneer

$53.84

1.85 (3.56%)

VIRT

Virtu Financial

$22.05

(0.00%)

INAP

Internap

$13.69

1.3 (10.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 29

    Oct

  • 12

    Nov

  • 15

    Nov

  • 27

    Nov

LYB

LyondellBasell

$101.66

-0.5 (-0.49%)

, PAH

Platform Specialty Products

$12.68

-0.12 (-0.94%)

10:22
09/19/18
09/19
10:22
09/19/18
10:22
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

LYB

LyondellBasell

$101.66

-0.5 (-0.49%)

PAH

Platform Specialty Products

$12.68

-0.12 (-0.94%)

KBR

KBR

$19.64

-0.55 (-2.72%)

OMAB

OMA Airports

$56.32

0.14 (0.25%)

NOK

Nokia

$5.44

-0.18 (-3.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$12.45

0.52 (4.36%)

, TSM

TSMC

$43.97

0.4 (0.92%)

10:22
09/19/18
09/19
10:22
09/19/18
10:22
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

RIG

Transocean

$12.45

0.52 (4.36%)

TSM

TSMC

$43.97

0.4 (0.92%)

MTL

Mechel

$2.84

0.22 (8.40%)

JNPR

Juniper

$29.11

0.51 (1.78%)

ETFC

E-Trade

$55.55

1.78 (3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 11

    Oct

  • 16

    Oct

APPS

Digital Turbine

$1.25

(0.00%)

10:21
09/19/18
09/19
10:21
09/19/18
10:21
Conference/Events
Digital Turbine management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 24

    Sep

  • 15

    Nov

AMBR

Amber Road

$8.86

(0.00%)

10:20
09/19/18
09/19
10:20
09/19/18
10:20
Conference/Events
Amber Road management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

DWDP

DowDuPont

$68.96

0.925 (1.36%)

10:20
09/19/18
09/19
10:20
09/19/18
10:20
Options
DowDupont draws short-term call buying as shares see strength »

DowDupont draws…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
09/19/18
09/19
10:17
09/19/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/19/18
09/19
10:16
09/19/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
09/19/18
09/19
10:15
09/19/18
10:15
General news
FX Action: USD-CAD »

FX Action: USD-CAD fell…

10:15
09/19/18
09/19
10:15
09/19/18
10:15
General news
Breaking General news story  »

Week of 9/14 EIA…

RMNI

Rimini Street

$6.03

-0.56 (-8.50%)

10:10
09/19/18
09/19
10:10
09/19/18
10:10
Hot Stocks
Breaking Hot Stocks news story on Rimini Street »

Rimini Street Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KELYA

Kelly Services

$24.55

0.07 (0.29%)

10:10
09/19/18
09/19
10:10
09/19/18
10:10
Hot Stocks
Kelly Services announces retirement of chairman Terence Adderley »

Kelly Services announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$46.16

0.05 (0.11%)

10:10
09/19/18
09/19
10:10
09/19/18
10:10
Options
Second day this week of three-way spreads in Intel »

Second day this week of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

WHLR

Wheeler REIT

$4.15

(0.00%)

10:08
09/19/18
09/19
10:08
09/19/18
10:08
Hot Stocks
The Stilwell Group urges Wheeler REIT shareholders to vote for its nominees »

The Stilwell Group, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIOD

Diodes

$32.73

0.04 (0.12%)

10:06
09/19/18
09/19
10:06
09/19/18
10:06
Upgrade
Diodes rating change  »

Diodes upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMNI

Rimini Street

$5.62

-0.97 (-14.72%)

10:05
09/19/18
09/19
10:05
09/19/18
10:05
Hot Stocks
Breaking Hot Stocks news story on Rimini Street »

Rimini Street Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YGYI

Youngevity

$4.10

(0.00%)

10:05
09/19/18
09/19
10:05
09/19/18
10:05
Conference/Events
Youngevity management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

10:05
09/19/18
09/19
10:05
09/19/18
10:05
General news
U.S. corporate bond update: more issuance is on the way, though it's thinning »

U.S. corporate bond…

XYF

X Financial

$0.00

(0.00%)

10:04
09/19/18
09/19
10:04
09/19/18
10:04
Syndicate
Breaking Syndicate news story on X Financial »

X Financial indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.